117 – Patient Registries & Long-Term Studies (S8E12)

Have you ever thought about when a new treatment,
a new drug or therapy comes out, how do we really
know how it's gonna affect people way down the
line? Not just in the next few weeks or months,
but five, 10, maybe even 20 years later. Yeah,
absolutely. Especially for those chronic conditions,
the ones people live with for years. Of course.
Or when a medication's been on the market for
a while and tons of people are taking it. Right.
What happens then? It's something I've definitely
thought about a lot. And I bet you have, too,
if you're into following medical news or if you
or someone you know is dealing with a health
issue. Makes sense. So that's what we're going
to really get into today, the whole world of
how we figure out the long -term impacts of these
treatments. OK, sounds good. We're talking about
patient registries and long -term studies, those
things that track what happens to people over
time. Yeah, those are really important tools.
They are super important. And you might kind
of know what a registry is, but in the medical
world, it's basically a way to gather all this
data on patients who have the same condition
or who've gotten a certain treatment. It's like
building this huge detailed record of what their
health journey is like, you know? Right, like
a long -term picture instead of just a snapshot.
Exactly. And they're designed to collect this
info over a really long time. Yeah. So we can
start to see those patterns and really understand
how these treatments are affecting people in
the real world. Yeah. And way beyond what those
initial clinical trials can tell us. For sure.
So today we're going to unpack how these registries
are put together. how they work, we'll look at
the key parts of the design, how they collect
data, and probably the most important thing,
how they analyze all that data to give us insights
into whether these treatments are really safe
and effective over the long haul. Yeah. That
analysis part is crucial. It is. And learning
about all this, it's really relevant for everyone.
It helps us understand how medical knowledge
keeps growing and changing. It's not static.
Not at all. It's always evolving. as we learn
more from what's happening out in the real world.
And that means better healthcare for all of us.
Exactly. So let's jump right in. Okay. When we
talk about the big picture of medicine and how
we learn about treatments, what's the fundamental
reason these patient registries exist? What's
that big need they fill? Well, at their core,
they're meant for those long -term safety and
outcome studies. Okay. So those early clinical
trials, you know, the phase two trials, they're
super important. They tell us a lot about how
toxic a treatment might be and how the body reacts
in the short term. Okay. But they often don't
have the scope. Yeah. You know, the size or the
length of time to catch everything. That makes
sense. Like say there's a side effect that only
pops up in a small number of patients. Okay.
Or maybe it takes years to develop. Right. Those
early trials might totally miss it. So like if
it's a rare thing or something that takes a while
to show up? Exactly. It could fly under the radar
in those initial trials. Exactly, and that's
where registries come in. Okay. They're big,
and they go on for a long time, so they're really
valuable. Okay. By tracking data from many more
patients and for a longer time, and doing it
in those everyday clinical settings, you know?
Right. We get a way better chance of finding
those less common side effects, the ones that
might not show up in a controlled trial. So it's
like casting a wider net and watching for longer.
Exactly. And it's not only about spotting problems,
right? These registries also give us a much clearer
picture of whether a treatment actually works
in the long run outside of that controlled environment
of a trial. because a treatment might look super
effective in a trial where everything is really
controlled and patients are carefully selected,
but then in the real world where people have
other health issues or are taking other medications,
maybe they don't always follow the treatment
plan perfectly. Yeah, life happens. Those registries
show us how well the treatment really works over
the long term. in that messy real world. Exactly.
So beyond safety and effectiveness, are there
other insights we can get from this kind of long
-term data collection? Oh, for sure. We can learn
a ton about how diseases naturally progress over
time. Oh, okay. So say you have a registry for
a certain autoimmune disease. Okay. Researchers
can track how that disease changes in different
people. Yeah. They can find things that might
predict if someone will have a more severe case
or see how lifestyle choices affect the outcome.
So it's like putting together a super detailed
timeline of the disease itself. Yes. And also
how different treatments affect that timeline
for a large group of people. Exactly. That's
super cool. Okay, so let's shift gears a bit
and talk about how these registries are actually
designed. Okay. What are those essential pieces
that go into making a really effective patient
registry? Right. Like if you're starting from
scratch and you want to build one of these massive
data gathering systems. Where do you even begin?
Well, the very first thing you got to do is figure
out exactly who's going to be in the registry.
You got to set up really clear criteria for who
can participate and who can't. Yeah. This is
where you think carefully about the patients.
You want to study their condition, the treatment
they got, all that. Because this definition is
what helps you account for other things that
could be affecting the outcomes. OK. Things like
other health problems they might have or other
treatments they're getting. So you have to be.
super specific about who you're tracking to make
sure that data you get is actually useful and
that you can compare apples to apples. Exactly
you said it perfectly. So what specific info
are they actually collecting from these patients?
Well it depends on what the registry is trying
to achieve. Okay. But generally you'll see details
about the treatment itself. Like what? Like the
exact medication or therapy, the dosage, how
long they've been on it, that kind of thing.
Got it. They also collect important patient characteristics
like age, gender, other conditions. They have
a medical history. And of course, a big focus
is on tracking outcomes. How's their health changing
their quality of life and any bad side effects
they might be experiencing. And how often you
collect this data. That's another really important
part of the design. OK, so this sounds like a
ton of information to manage. Yeah, it could
be a lot. potentially thousands of people over
many years. How do they even make sure all that
data is accurate and consistent across everyone
and over all that time? That's a great question
and it's crucial to get it right. Yeah. So typically
they use standardized forms for data collection.
and they have very clear rules that everyone
involved in entering that data has to follow.
Okay, that makes sense. And we're seeing more
and more digital tools being used to help with
all this, you know, things like apps and wearables.
Oh, yeah, those are getting popular. They are,
and they can really help patients report symptoms,
track their medications, and send in other info
directly. So cutting out some of that manual
data entry? Yeah, and it probably helps with
getting more frequent updates. Yeah, I bet. But
with this shift toward digital, What are some
of the new challenges we have to think about?
Oh, that's a great point. As we start relying
more on digital healthcare technologies, we got
to make sure those old regulatory systems keep
up. Right. Because even though these digital
tools offer a lot of benefits, we need good ways
to monitor them for safety and make sure they're
actually working the way they should. That makes
sense. So regulatory bodies are working hard
with different groups to set standards and make
sure everyone is accountable as this technology
keeps developing. It's like a whole new frontier.
It really is. OK, so you've got the registry
set up. You're collecting tons of data. Right.
Now what? How do you take all that raw info and
turn it into something meaningful insights about
long -term safety and how well these treatments
are working? That's where the analysis comes
in. And it's a big job. You got to use some pretty
sophisticated methods to handle all that data.
And it's complex data. So you need powerful statistical
analysis to spot trends and connections between
treatments and outcomes and any signs of safety
problems that might be popping up over time.
So you can't just look at the raw numbers. Not
at all. You need these special statistical techniques
to really dig in and find those hidden patterns.
Exactly. An analyst might compare different groups
within the registry. Like what call groups? Like
people who got one treatment versus another.
Okay. They're looking for differences that are
statistically significant, you know? That could
mean one group has a higher risk of side effects.
Right. Or a better chance of a good outcome.
Okay. And, you know, analyzing data collected
over many years comes with its own set of challenges.
Oh, yeah. I bet, like, what? Well, one of the
biggest is dealing with what we call confounding
factors. These are other variables that could
be influencing the outcomes, making it tough
to isolate the real effect of the treatment.
OK, can you give me an example of that? Sure.
So imagine one group in the registry happens
to be a lot older. OK. Or they have more health
problems to begin with. Right. Those factors
could be affecting their outcomes, regardless
of what treatment they're getting. Oh, that makes
sense. So analysts have to use statistical adjustments
to account for all this complexity. So it's like
untangling a big knot. Yeah, that's a good way
to put it. Trying to separate the real impact
of the treatment from everything else that could
be going on. Exactly. OK, so can you give us
some real world examples of how these registries
are actually being used to help us understand
long term safety and how well treatments work?
Absolutely. Let's start with those registries
for chronic diseases. OK. These are super helpful
for things like certain. cancers or autoimmune
disorders, the ones people live with for years.
These registries track a lot of patients over
a long period and document how their disease
is changing, what treatments they're getting,
and what their health outcomes are like over
time. So for example, someone with a rare type
of cancer, a registry could pull data from patients
across many different hospitals, maybe even different
countries. That would give researchers a way
broader view than any single hospital could get
on its own. That's the idea, and it lets researchers
spot factors that might... influence how the
disease progresses or how well someone responds
to different therapies. So it's like a global
collaboration. Exactly. Okay, that makes sense.
So what about after a medication has already
gotten approval, you know, from the FDA or whatever,
and it's available to everyone, how do registries
contribute them? That's where post -market drug
monitoring comes in. Okay. And registries are
a key part of that. Okay. Even after all those
rigorous clinical trials, some side effects might
not show up. until the drug is being used by
tons of people out in the real world. So something
that only affects a small percentage of people,
or that takes a while to develop, might not show
up until much later. Exactly. And registries
act as a kind of safety net to help us catch
those unexpected issues. So like if a few years
after a new drug is released, a small group of
people start having a certain side effect, a
good registry could help. spot that trend. Absolutely.
And that could lead to safety alerts, changes
to how doctors prescribe the drug. OK. Or in
some cases, if the risks are bigger than the
benefits, the drug could even be pulled off the
market. So it really shows that we're always
learning about the safety of medications. Right.
Even after they're out there. It's an ongoing
process. What about this really complex treatments
like biologics? Ah, yes, biologics. They're a
whole other ball game. Yeah. They're often derived
from living organisms. Right. And registries
are especially important for tracking them in
the long term. OK. One thing we look at is immunogenicity.
OK. That's when the patient's body starts making
an immune response against the drug. Oh, wow.
And that can make the drug less effective or
even cause bad reactions. So the body is fighting
the treatment. In a way, yeah. Wow. And registries
help us understand how often this happens and
if it's a big problem clinically. So with these
biologics, which are often really expensive.
Yeah. Registries help us make sure we understand
their long -term effects. Exactly. Including
whether the body might eventually stop responding
to them. Yeah. And we also look for any other
long -term effects that might come up because
these molecules are complex. Wow. They interact
with the body in a lot of different ways. Right.
So keeping an eye on them through registries
is super important. Really important. OK, so
we've talked a lot about how these registries
work and why they're important. Yeah. What do
you see as some of the biggest benefits we've
gotten from using them over the years? Oh, there
are a lot of benefits. I mean, first, like we
talked about, they give us a much better overall
understanding of how safe and effective treatments
are in the real world. Right, not just in a clinical
trial. Exactly. And they're super valuable for
finding those rare side effects that might not
show up in the early trials. Right. And they
give us important clues about how diseases progress
naturally over time and all the different things
that can influence that. And all of that feeds
into how doctors make decisions about treatment.
Absolutely. It helps them make more informed
choices for their patients. So, evidence -based
medicine. Exactly. Now, have there been any big
lessons learned about how to set up and use these
registries most effectively? Definitely. One
of the biggest is that you absolutely need high
-quality data. Makes sense. If the info you're
collecting is incomplete or inaccurate or inconsistent,
then any analysis you do and any conclusions
you draw from, it won't be reliable. Right. Garbage
and garbage out. Exactly. And getting patients
involved is really important too. Yeah. You need
people to be willing to participate and share
their info over a long period. So explaining
the purpose of the registry clearly and making
sure people have a good experience, that's all
essential. And the last thing we've learned is
that these registries can't be static. They need
to be flexible. Sometimes you need to change
the design or what data you're collecting as
we learn more about. the disease or the treatment.
So it's a constant process of improvement. It
is. To make sure these registries stay relevant.
To wrap things up, can you just remind us why
these patient registries and long -term studies
are so crucial to moving healthcare forward?
They're really the foundation for making sure
that treatments aren't just effective in the
short term, but stay safe and beneficial for
patients throughout their lives. Right. They
give us that real world evidence that adds to
what we learn from clinical trials. So we get
a much more complete picture of how these treatments
impact people's lives. It's amazing to think
about all the data that's being collected and
analyzed to make health care better. It really
shows how medicine is always learning and changing.
Absolutely, and it makes you think about the
future too. Yeah, like what? How might all these
new technologies like digital health and artificial
intelligence totally change how we use and learn
from these registries? Right. We're already seeing
the potential of AI to analyze huge amounts of
complex data like genetic info and medical images
and even to predict what treatment might work
best. So imagine what we could do if we combine
these advanced technologies with all the rich
long -term data from patient registries. That's
pretty exciting. It is. So for anyone listening
who wants to learn more about this, I'd recommend
checking out the resources from agencies like
the US FDA. Yeah, good idea. They're the ones
who approve new drugs and devices and they keep
track of safety. once those things are on the
market. And their websites usually have a ton
of info about drug safety and how they protect
patients. That's a great place to start. So keep
learning, everyone. Thanks for joining us for
this deep dive. Thanks for having me. It's been
a pleasure. Likewise. Until next time. See you
then.